EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Adjunctive Pharmacotherapy for Major Depressive Disorder with Anxiety Symptoms: from Monoamines to Recent Clinical Evidence

Roger S McIntyre, Masaki Kato, Michael E Thase, François Therrien, A Marilise Marrache, Kenta Ikehara, Ferhat Ardic, Matthieu Boucher

CNS Drugs · 2026-09 · 40 (9) · 1185-1206

DOI: 10.1007/s40263-026-01315-7 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift CNS Drugs, online erschienen am 28.07.2026. Verfasst von Roger S McIntyre und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, University of Toronto, 250 College Street 8th floor, Toronto, ON, M5T 1R8, Canada. roger.mcintyre@bcdf.org. Hauptthemen laut MEDLINE: Major Depressive Disorder, Antidepressive Agents, Biogenic Monoamines, Anxiety Disorders. Die Arbeit nennt 164 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Otsuka Canada Pharmaceutical, Lundbeck Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Major Depressive DisorderAntidepressive AgentsBiogenic MonoaminesAnxiety DisordersAnxietyAntipsychotic AgentsHumansAnimals

Substanzen

Antidepressive AgentsBiogenic MonoaminesAntipsychotic Agents

Autor:innen und Institutionen

  • Department of Psychiatry, University of Toronto, 250 College Street 8th floor, Toronto, ON, M5T 1R8, Canada. roger.mcintyre@bcdf.org.
  • Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada. roger.mcintyre@bcdf.org.
  • Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan.
  • Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Philadelphia Veterans Affairs Medical Center, Philadelphia, PA, USA.
  • Otsuka Canada Pharmaceutical Inc., Saint-Laurent, QC, Canada.

Förderung

  • Otsuka Canada Pharmaceutical
  • Lundbeck Canada

Zitieren

APA

McIntyre, R. S., Kato, M., Thase, M. E., Therrien, F., Marrache, A. M., Ikehara, K., Ardic, F., & Boucher, M. (2026). Adjunctive Pharmacotherapy for Major Depressive Disorder with Anxiety Symptoms: from Monoamines to Recent Clinical Evidence. CNS Drugs, 40(9), 1185-1206. https://doi.org/10.1007/s40263-026-01315-7

Vancouver

McIntyre RS, Kato M, Thase ME, Therrien F, Marrache AM, Ikehara K, et al. Adjunctive Pharmacotherapy for Major Depressive Disorder with Anxiety Symptoms: from Monoamines to Recent Clinical Evidence. CNS Drugs. 2026;40(9):1185-1206. doi:10.1007/s40263-026-01315-7

BibTeX
@article{McIntyre2026,
  author = {McIntyre, Roger S and Kato, Masaki and Thase, Michael E and Therrien, François and Marrache, A Marilise and Ikehara, Kenta and Ardic, Ferhat and Boucher, Matthieu},
  title = {Adjunctive Pharmacotherapy for Major Depressive Disorder with Anxiety Symptoms: from Monoamines to Recent Clinical Evidence},
  journal = {CNS Drugs},
  year = {2026},
  volume = {40},
  number = {9},
  pages = {1185--1206},
  doi = {10.1007/s40263-026-01315-7}
}
Kostenlos starten →